More interestingly, the expression or mutation of FGF9 correlates with β-catenin in ovarian, colorectal and endometrial carcinomas (Abdel-Rahman et al., 2008; Hendrix et al., 2006). This evidence concerns the gene FGF9 and endometrial carcinoma.